$168.03
0.40%
NYSE, Mar 28, 09:13 pm CET
ISIN
US7427181091
Symbol
PG

Procter & Gamble Target price 2025 - Analyst rating & recommendation

Procter & Gamble Classifications & Recommendation:

Buy
61%
Hold
35%
Sell
3%

Procter & Gamble Price Target

Target Price $182.00
Price $168.03
Potential 8.31%
Number of Estimates 25
25 Analysts have issued a price target Procter & Gamble 2026 . The average Procter & Gamble target price is $182.00. This is 8.31% higher than the current stock price. The highest price target is $209.00 24.38% , the lowest is $157.00 6.56% .
A rating was issued by 31 analysts: 19 Analysts recommend Procter & Gamble to buy, 11 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Procter & Gamble stock has an average upside potential 2026 of 8.31% . Most analysts recommend the Procter & Gamble stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2028


Jun '24 2025
Estimates
Revenue Billion $ 84.04 85.16
2.48% 1.34%
EBITDA Margin 27.48% 28.03%
6.95% 2.00%
Net Margin 16.80% 18.63%
0.43% 10.91%

22 Analysts have issued a sales forecast Procter & Gamble 2025 . The average Procter & Gamble sales estimate is $85.2b . This is 0.97% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $86.2b 2.19% , the lowest is $83.7b 0.81% .

This results in the following potential growth metrics:

Revenue Estimates

2024 $84.0b 2.48%
2025 $85.2b 1.34%
2026 $88.0b 3.29%
2027 $91.5b 3.97%
2028 $95.3b 4.17%

19 Analysts have issued an Procter & Gamble EBITDA forecast 2025. The average Procter & Gamble EBITDA estimate is $23.9b . This is 5.73% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $24.3b 7.53% , the lowest is $23.0b 1.99% .

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $23.1b 9.60%
2025 $23.9b 3.36%
2026 $25.4b 6.37%
2027 $27.0b 6.30%
2028 $28.0b 3.75%

EBITDA Margin

2024 27.48% 6.95%
2025 28.03% 2.00%
2026 28.86% 2.96%
2027 29.51% 2.25%
2028 29.39% 0.41%

11 Procter & Gamble Analysts have issued a net profit forecast 2025. The average Procter & Gamble net profit estimate is $15.9b . This is 7.74% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $16.4b 11.31% , the lowest is $15.3b 4.14% .

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $14.1b 2.03%
2025 $15.9b 12.40%
2026 $17.3b 9.04%
2027 $18.6b 7.24%
2028 $19.7b 6.34%

Net Margin

2024 16.80% 0.43%
2025 18.63% 10.91%
2026 19.67% 5.58%
2027 20.28% 3.10%
2028 20.71% 2.12%

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028


Jun '24 2025
Estimates
Earnings Per Share $ 6.02 6.77
2.03% 12.46%
P/E 24.83
EV/Sales 4.93

11 Analysts have issued a Procter & Gamble forecast for earnings per share. The average Procter & Gamble EPS is $6.77 . This is 7.80% higher than earnings per share in the financial year 2024. The highest EPS forecast is $6.99 11.31% , the lowest is $6.54 4.14% .

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $6.02 2.03%
2025 $6.77 12.46%
2026 $7.38 9.01%
2027 $7.91 7.18%
2028 $8.41 6.32%

P/E ratio

Current 26.77 1.11%
2025 24.83 7.25%
2026 22.77 8.30%
2027 21.24 6.72%
2028 19.97 5.98%

Based on analysts' sales estimates for 2025, the Procter & Gamble stock is valued at an EV/Sales of 4.93 and an P/S ratio of 4.63 .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 4.97 2.47%
2025 4.93 0.89%
2026 4.77 3.19%
2027 4.59 3.82%
2028 4.40 4.00%

P/S ratio

Current 4.67 3.07%
2025 4.63 0.96%
2026 4.48 3.19%
2027 4.31 3.82%
2028 4.14 4.00%

Current Procter & Gamble Upgrades & Downgrades

Analyst Rating Action Date
Barclays
Equal-Weight
Equal-Weight
Unchanged Mar 27 2025
Piper Sandler
Neutral
Neutral
Unchanged Feb 24 2025
Wells Fargo
Overweight
Overweight
Unchanged Jan 23 2025
Barclays
Equal-Weight
Equal-Weight
Unchanged Jan 23 2025
DA Davidson
Buy
Buy
Unchanged Jan 23 2025
Stifel
Hold
Hold
Unchanged Jan 23 2025
RBC Capital
Sector Perform
Sector Perform
Unchanged Jan 23 2025
Analyst Rating Date
Unchanged
Barclays:
Equal-Weight
Equal-Weight
Mar 27 2025
Unchanged
Piper Sandler:
Neutral
Neutral
Feb 24 2025
Unchanged
Wells Fargo:
Overweight
Overweight
Jan 23 2025
Unchanged
Barclays:
Equal-Weight
Equal-Weight
Jan 23 2025
Unchanged
DA Davidson:
Buy
Buy
Jan 23 2025
Unchanged
Stifel:
Hold
Hold
Jan 23 2025
Unchanged
RBC Capital:
Sector Perform
Sector Perform
Jan 23 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today